Pay in 4 interest-free payments of $116.25 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
9449-9453 DOI: 10
1039/C3SC22015J
2) Thoreau
Platform for Orthogonal N-Cysteine-Specific Protein Modification Enabled by Cyclopropenone Reagents
Trifunctional Dibromomaleimide Reagents Built Around A Lysine Scaffold Deliver Site-selective Dual-modality Antibody Conjugation
Dibromopyridazinediones-N-ethyl-N'-Propanamido-PEG3-C3-TCO Quantity:500 mg 9449-9453 DOI: 10References: Schauenburg, D.; et al. Macrocyclic Dual Locked Turn On Drug for Selective and Traceless Release in Cancer Cells Angew. Chem. Int. Ed. (2024), 63, e202314143 DOI: 10. 1002 anie. 202314143 Keywords: Traceless Release; Bis sulfone; DBCO
US$ 100.56
US$ 382.26
US$ 2755.76
US$ 571.41
US$ 192.83
US$ 375.06
US$ 154.12
US$ 270.64
US$ 218.74
US$ 230.41
US$ 173.38
US$ 203.10
US$ 159.38
US$ 187.35
US$ 528.91
US$ 572.93